Close
ACHEMA MIDDLE EAST 2026
17TH Global Drug Delivery & Formulation Summit 2026

FDA Approvals

Lokelma approved in China for the treatment of adult patients with hyperkalaemia

FDA Approvals
AstraZeneca’s Lokelma has been approved in China for the treatment of adult patients with hyperkalaemia (elevated levels of potassium in the blood). The approval by...

Elsevier and FDA to work on AI algorithm for drug-induced liver injury

FDA Approvals
Elsevier is working with the National Center for Toxicological Research (NCTR) at the FDA on a predictive drug-induced liver injury (DILI) algorithm. The company...

Aquestive Therapeutics Receives FDA Approval for Exservan Oral Film

FDA Approvals
Aquestive Therapeutics, a specialty pharmaceutical company focused on developing and commercializing differentiated products to solve therapeutic problems, announced that Exservan Oral Film received early-action...

CHMP Recommends Approval of Dupixent for Severe Chronic Rhinosinusitis with Nasal Polyposis

FDA Approvals
Regeneron Pharmaceuticals, Inc. and Sanofi announced that the European Medicines Agency'sCommittee for Medicinal Products for Human Use (CHMP) has adopted a positive opinion for...

DiscGenics Receives FDA Fast Track Designation for Cell Therapy for Disc Degeneration

FDA Approvals
 DiscGenics, Inc., a clinical stage biotechnology company focused on developing regenerative cell-based therapies that alleviate pain and restore function in patients with degenerative diseases...

Dynacure Receives Orphan Drug Designation from the US FDA for DYN101 an Antisense Medicine to Treat Rare Disease Centronuclear Myopathies

FDA Approvals
Dynacure, a clinical stage drug development company focused on improving the lives of patients with rare and orphan disorders, announced that the U.S. FDA...

Stoke Therapeutics Granted FDA Orphan Drug Designation for STK-001, an Investigational New Treatment for Dravet Syndrome

FDA Approvals
Stoke Therapeutics, Inc , a biotechnology company pioneering a new way to treat the underlying cause of genetic diseases by precisely upregulating protein expression,...

Subscribe Our Newsletter

White Papers

The Future of Digital Health

Whitepapers 0
The pharmaceutical industry is acutely aware that the future of health and care, particularly in the United States, are trending toward a digital revolution....

Five Best Practices to Deliver Exceptional Multichannel Experiences

Whitepapers 0
A one-size-fits-all customer journey no longer works. In the age of the consumer, the quality of the interaction is paramount. In this paper, we...

The Impact and Use of Social Media in Pharmacovigilance

Whitepapers 0
Social media presents new channels and methods for biopharmaceutical companies to move away from traditional pharmacovigilance (PV) systems and safety reporting methods towards more...

About us

Pharma Advancement is a leading Pharma information centric website. On one side Pharmaadvancement.com has established itself as one of the most efficient and
comprehensive source of Pharma information online, dedicated to providing decision makers in all the Pharma industry sectors with reliable, accurate and useful insights into happenings in the Pharma sector. . . Read More

Resources

Advertise

Subscribe

Copyright © Value Media Group 2026. All rights reserved.